Cellebrite DI Ltd. logo

Cellebrite DI Ltd.

CLBT | NASDAQ
Chart Builder DCF Calculator
$12.15
-$0.13 (-1.06%)
At close: Oct 30, 2026, 3:59 PM ET
$12.11
-$0.04 (-0.33%)
Pre-market: Nov 2, 2026, 4:10 AM ET
-1.06%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026
72.1
+12.5 pts
Fundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #86/819 (Top 11%)

Key Statistics

Market Data

Market Cap $3.05B
1D Range
12.02 12.27
52W Range
10.44 19.28

Valuation (TTM)

PE 52.83
PB 5.68
EV/EBITDA 23.18

Valuation (NTM)

Forward PE 33.13
Forward PEG -3.13
Price Target $14.13
Loading financial charts...

Profile

Cellebrite DI Ltd. delivers specialized digital intelligence solutions crafted for legally authorized investigations. Their comprehensive DI platform enables users to efficiently gather, scrutinize, i...

Sector Technology
Employees 1,285
IPO Date Nov 6, 2020
Fiscal Year January - December

Latest News

Genesis Momentum Powers Cellebrite's Autumn Release: More Evidence, Deeper Insight, Broader Access for Investigations

12 days ago · prnewswire.com

Genesis Momentum Powers Cellebrite's Autumn Release: More Evidence, Deeper Insight, Broader Access for Investigations
Cellebrite publiera ses résultats financiers du troisième trimestre 2026 le 12 novembre 2026

13 days ago · prnewswire.com

Cellebrite publiera ses résultats financiers du troisième trimestre 2026 le 12 novembre 2026

13 days ago · prnewswire.com

Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026
Kaplan Fox is Investigating Cellebrite DI Ltd. (CLBT) for Investors Who Suffered Losses

27 days ago · newsfilecorp.com

Kaplan Fox is Investigating Cellebrite DI Ltd. (CLBT) for Investors Who Suffered Losses
CLBT INVESTIGATION: Cellebrite Investigated by Block & Leviton; Investors Should Contact the Firm to Possibly Recover Losses

1 month ago · newsfilecorp.com

CLBT INVESTIGATION: Cellebrite Investigated by Block & Leviton; Investors Should Contact the Firm to Possibly Recover Losses
Kaplan Fox Urges Investors of Cellebrite DI Ltd. (CLBT) with Losses to Contact the Firm

1 month ago · newsfilecorp.com

Kaplan Fox Urges Investors of Cellebrite DI Ltd. (CLBT) with Losses to Contact the Firm

1 month ago · fool.com

Cellebrite's 2026 Outlook: Subscription Pivot Weighs on the Stock Today, Helps Lead a Future Rebound
Kaplan Fox Is Investigating Cellebrite DI Ltd. (CLBT) on Behalf of Shareholders for Possible Securities Law Violations

1 month ago · newsfilecorp.com

Kaplan Fox Is Investigating Cellebrite DI Ltd. (CLBT) on Behalf of Shareholders for Possible Securities Law Violations
Cellebrite Calls for 2027 JUSTYS Nominees, Premier Event Highlights Unsung Heroes Who Keep the World Safe

1 month ago · prnewswire.com

Cellebrite Calls for 2027 JUSTYS Nominees, Premier Event Highlights Unsung Heroes Who Keep the World Safe

1 month ago · newsfilecorp.com

Kaplan Fox Notifies Investors of Cellebrite DI Ltd. (CLBT) of a Securities Law Investigation

Earnings

Next Earnings
Nov 12, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
5
Consensus
Buy
Price Target
$14.50
Upside
+19.34%
Buy (5)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.